Assembly-private panel discussion gains no fruit

Lawmakers of the National Assembly’s Health and Welfare Committee and four law and patent experts held a public hearing on Monday over the impacts that its free trade deals with the U.S. would cause in domestic pharmaceutical sector in the future, but unfortunately it ended with no outcomes.

The domestic pharmaceutical sector is expected to face an inevitable blow with major drug companies f...